Enantiomers of sulfoxide of albendazole: cerebrospinal fluid and plasma levels and therapeutic efficacy in the treatment of patients with neurocysticercosis

Enantiomers of sulfoxide of albendazole: cerebrospinal fluid and plasma levels and therapeutic efficacy in the treatment of patients with neurocysticercosis

Saved in:

Bibliographic Details
Main Author:	Newton Satoru Odashima
Format:	Article
Language:	English
Published:	Thieme Revinter Publicações 2003-06-01
Series:	Arquivos de Neuro-Psiquiatria
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2003000200033
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Analysis of cerebrospinal fluid in racemose form of neurocysticercosis
by: Rodrigo Bazan, et al.
Published: (2015-01-01)

Enzyme linked immunosorbent assay (ELISA) for detection of IgG, IgM, IgE and IgA against cysticercus cellulosae in cerebrospinal fluid in neurocysticercosis (abstract) Reações imunoenzimáticas para detecção de IgG, IgM, IgE e IgA anticisticerco no líquido cefalorraquiano na neurocisticercose (Resumo)
by: Newton Satoru Odashima
Published: (1997-09-01)

Enzyme linked immunosorbent assay (ELISA) for the detection of IgG, IgM, IgE and IgA against Cysticercus cellulosae in cerebrospinal fluid of patients with neurocysticercosis
by: Odashima Newton Satoru, et al.
Published: (2002-01-01)

Praziquantel in the cerebrospinal fluid in neurocysticercosis
by: A. Spina-França, et al.
Published: (1985-09-01)

Severe forms of neurocysticercosis: treatment with albendazole Formas graves da neurocisticercose: tratamento com albendazol
by: Svetlana Agapejev, et al.
Published: (1996-03-01)

Clinical, radiological and cerebrospinal fluid presentation of neurocysticercosis: a prospective study
by: P. R. M. Bittencourt, et al.
Published: (1990-09-01)

Impact of albendazole treatment on the symptom profile of neurocysticercosis patients 14–16 years following diagnosis
by: Lucila Vilela, et al.

Neurocysticercosis detected by targeted next-generation sequencing of cerebrospinal fluid: a case report
by: Xintong Ren, et al.
Published: (2025-04-01)

Neurocysticercosis: relationship between Taenia antigen detection in the cerebrospinal fluid and magnetic resonance imaging
by: Ronaldo Abraham
Published: (2006-12-01)

Human neurocysticercosis: IgE in cerebrospinal fluid Neurocisticercose humana: IgE no líquido cefalorraquiano
by: Carmen Silvia de Melo, et al.
Published: (1997-01-01)

Behaviour of indirect immunofluorescence test and some cerebrospinal parameters in neurocysticercosis
by: Amauri Braga Simonetti, et al.
Published: (1987-03-01)

Elevated Levels of Cerebrospinal Fluid and Plasma Interleukin-37 in Patients with Guillain-Barré Syndrome
by: Cong Li, et al.
Published: (2013-01-01)

Systemic Administration of Glibenclamide Fails to Achieve Therapeutic Levels in the Brain and Cerebrospinal Fluid of Rodents.
by: Carolina Lahmann, et al.
Published: (2015-01-01)

Determination and Pharmacokinetics of Omeprazole Enantiomers in Human Plasma and Oral Fluid Utilizing Microextraction by Packed Sorbent and Liquid Chromatography-Tandem Mass Spectrometry
by: Hytham Ahmed, et al.
Published: (2021-01-01)

Increased cerebrospinal fluid and plasma apoE glycosylation is associated with reduced levels of Alzheimer’s disease biomarkers
by: Dobrin Nedelkov, et al.
Published: (2025-07-01)

Plasma exchange with albumin replacement for Alzheimer's disease treatment induced changes in serum and cerebrospinal fluid inflammatory mediator levels
by: Ricardo Gonzalo, et al.
Published: (2024-12-01)

Deoxydichlorination of aldehydes catalyzed by Diphenyl sulfoxide
by: I. A. Gorbunova, et al.
Published: (2021-12-01)

Electrogenerated chemiluminescence of violanthrone in dimethyl sulfoxide
by: K. Hansongnern, et al.
Published: (1999-01-01)

DIAGNOSTIC VALUE OF pTAU AND NF-L LEVELS IN CEREBROSPINAL FLUID AND PLASMA IN PATIENTS WITH TRAUMATIC BRAIN INJURY
by: Stela Yancheva, et al.
Published: (2024-04-01)

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
by: Sebastian Palmqvist, et al.
Published: (2019-11-01)

Multiple sclerosis has a distinct lipid signature in plasma and cerebrospinal fluid
by: Enedina Maria Lobato de OLIVEIRA, et al.
Published: (2019-10-01)

UPLC-MS/MS Method for Simultaneous Determination of 14 Antimicrobials in Human Plasma and Cerebrospinal Fluid: Application to Therapeutic Drug Monitoring
by: Huiting Sun, et al.
Published: (2022-01-01)

Neurocysticercosis: detection of IgG, IgA and IgE antibodies in cerebrospinal fluid, serum and saliva samples by ELISA with Taenia solium and Taenia crassiceps antigens
by: EDNÉIA CASAGRANDA BUENO, et al.
Published: (2000-03-01)

Efficacy of measuring lysophosphatidylcholine levels in human cerebrospinal fluid to differentiate myelopathy from cauda equina syndrome
by: Takuya Takahashi, et al.
Published: (2025-07-01)

Simultaneous Quantitative Determination of Synthetic Cathinone Enantiomers in Urine and Plasma Using GC-NCI-MS
by: Rashed Alremeithi, et al.
Published: (2018-01-01)

Serum procalcitonin and cerebrospinal fluid cytokines level in children with meningitis
by: A. Denizmen Aygun, et al.
Published: (2004-01-01)

Egg excretion patterns of soil-transmitted helminth infections in humans following albendazole-ivermectin and albendazole treatment.
by: Sophie Welsche, et al.
Published: (2024-03-01)

Uses of the Chiral Sulfoxide Group in Asymmetric Synthesis
by: Guy Solladié
Published: (1984-08-01)

Diagnostic and prognostic potential of cell-free RNAs in cerebrospinal fluid and plasma for brain tumors
by: Jinyong Huang, et al.
Published: (2025-04-01)

Cerebrospinal fluid shunt complications
by: E Güzelbağ, et al.
Published: (1997-07-01)

Efficacy and safety of albendazole alone versus albendazole in combination with ivermectin for the treatment of Trichuris trichiura infections: An open-label, randomized controlled superiority trial in south-western Uganda.
by: Marta Sólveig Palmeirim, et al.
Published: (2024-11-01)

The efficacy of the product Albendazole 10% of gastrointestinal nematode parasitism in sheep tested
by: Florin Stefan Hora, et al.
Published: (2014-12-01)

α-klotho as a biomarker of amyloid β levels in the cerebrospinal fluid
by: Jacob Raber, et al.
Published: (2025-06-01)

Postmortem serotonin level in cerebrospinal fluid as a marker of the manner of death
by: Damjanjuk Irina, et al.
Published: (2020-01-01)

Reduced Levels of Neurosteroids in Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis Patients
by: Chiara Lucchi, et al.
Published: (2024-08-01)

Stereoselectivity of In Vivo Processes and Bioactivity of Farrerol Enantiomers
by: Lirong Chen, et al.
Published: (2025-05-01)

Hydatid Cyst Rupture Due to Albendazole Treatment
by: Gökhan Polat, et al.
Published: (2025-07-01)

Neurocysticercosis
by: Beuy Joob, et al.
Published: (2014-03-01)

Neurocysticercosis
by: Osvaldo M. Takayanagui
Published: (2013-09-01)

Portable lactate analyzer for measuring lactate in cerebrospinal fluid (CSF) and plasma ? method-comparison evaluations
by: Sérgio Monteiro de Almeida, et al.
Published: (2014-07-01)